For researchers investigating skin biology at the cellular and molecular level, this compound is one of the most well-characterised tools available
In a 2021 study published in the New England Journal of Medicine, participants treated with semaglutide lost an average of about 15 percent of their body weight, compared with a loss of 2.4 percent in the placebo group
To address these concerns, future research should prioritize large-scale, longitudinal studies evaluating the long-term cardiovascular impacts of IF, particularly in vulnerable populations such as the elderly or those with preexisting cardiovascular conditions
Fares Qeadan, Ashlie McCunn, Benjamin Tingey: The association between glucosedependent insulinotropic polypeptide and/or glucagonlike peptide1 receptor agonist prescriptions and substancerelated outcomes in patients with opioid and alcohol use disorders: A realworld data analysis
Diabetologia 61 , 21082117 (2018)